Renal phosphate wasting due to tumor-induced osteomalacia: a frequently delayed diagnosis
Open Access
- 1 August 2009
- journal article
- case report
- Published by Elsevier in Kidney International
- Vol. 76 (3) , 342-347
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Tumor producing fibroblast growth factor 23 localized by two-staged venous samplingEuropean Journal of Endocrinology, 2008
- Radiofrequency Ablation of a Tumor Causing Oncogenic OsteomalaciaNew England Journal of Medicine, 2007
- PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Role of Fibroblast Growth Factor 23 in Phosphate Homeostasis and Pathogenesis of Disordered Mineral Metabolism in Chronic Kidney DiseaseSeminars in Dialysis, 2007
- “Phosphatonins” and the regulation of phosphorus homeostasisAmerican Journal of Physiology-Renal Physiology, 2005
- Parathyroidectomy for Tertiary Hyperparathyroidism Associated With X-linked Dominant Hypophosphatemic RicketsArchives of Surgery, 2004
- Most Osteomalacia-associated Mesenchymal Tumors Are a Single Histopathologic EntityAmerican Journal of Surgical Pathology, 2004
- The phosphatonin pathway: New insights in phosphate homeostasisKidney International, 2004
- Octreotide for Tumor-Induced OsteomalaciaNew England Journal of Medicine, 2002
- Indium-111 Pentetreotide Scintigraphy of Mesenchymal Tumor With Oncogenic OsteomalaciaClinical Nuclear Medicine, 1999
- NOMOGRAM FOR DERIVATION OF RENAL THRESHOLD PHOSPHATE CONCENTRATIONThe Lancet, 1975